Cat. No. | Product name | CAS No. |
DCC1742 |
Dequalinium Bromide
HIV-1 fusion inhibitor, targeting the membrane-proximal external region of Env spikes, specifically inhibiting the HIV-1 envelope-mediated membrane fusion by blocking CD4-induced conformational changes |
6707-58-0 |
DCC1743 |
Deramciclane Fumarate
Inhibitor of acetyl-CoA carboxylase (ACC), activating GPR40, inhibiting West Nile virus (WNV) infection and reducing the multiplication of Usutu virus (USUV), a WNV-related flavivirus |
120444-72-6 |
DCC1744 |
Desfluoro Ezetimibe
Desfluoro impurity of Ezetimibe |
302781-98-2 |
DCC1745 |
Desmethyl Mk-6884
Precursor for PET imaging 11C-radiolabeled MK-6884 |
|
DCC1746 |
Desmethyldiazepam
Primary metabolite of diazepam, binding to the GABA A receptor benzodiazepine modulatory site |
1088-11-5 |
DCC1747 |
Desmethyl-hd-800
PET precursor of preparing radiolabel [11C]HD-800, a high affinity brain penetrant PET tracer for imaging microtubules |
|
DCC1748 |
Desthiobiotin Polyethyleneoxide Iodoacetamide
Cysteine reactive protein labeling agent |
|
DCC1749 |
Dexamethasone 21-phosphate Disodium
Pro-drug of dexamethasone, anti-inflammatory glucocorticoid, stimulating glutamine uptake in the cerebral cortex |
55203-24-2 |
DCC1750 |
Dexamethasone Beloxil
Glucocorticoid, Anti-inflammatory Agent |
150587-07-8 |
DCC1751 |
Dexloxiglumide
Cholecystokinin antagonist, selective for the CCKA subtype |
119817-90-2 |
DCC1752 |
Dexmethylphenidate Hydrochloride
Norepinephrine-dopamine reuptake inhibitor (NDRI) |
19262-68-1 |
DCC1753 |
Dezocine
Natural modulator of mu-, delta-, and kappa-opioid receptors |
53648-55-8 |
DCC1754 |
Df-1012
5-HT3 Receptor antagonist; Antitussive; Anti-inflammatory; Antiasthmatic |
163220-65-3 |
DCC1755 |
Df-461
Potent Squalene Synthase Inhibitor |
927051-40-6 |
DCC1756 |
Dfk167
Cell-permeable, reversible and selective inhibitor of ɣ-secretase |
200810-93-1 |
DCC1757 |
Dfkbp-2
Proteolysis targeting chimeras (PROTAC), potently decreasing FKBP12 abundance in MV4;11 cells, leading to over 80% reduction of FKBP12 at 0.1 μM and 50% reduction at 0.01 μM |
|
DCC1758 |
Dg-051
Novel potent, orally active inhibitor of LTA4H |
929916-05-2 |
DCC1759 |
dgat2 Inhibitor 122
Selective inhibitor of diacylglycerol acyltransferase 2 (DGAT2) |
620931-38-6 |
DCC1760 |
Dg-c8-phip
The major adduct formed by the food-borne carcinogen, PhIP with DNA |
142784-25-6 |
DCC1761 |
Dgj-pfpht
Novel human α-galactosidase A ligand, capable of stabilizing α-Gal A and restoring trafficking |
1609458-32-3 |
DCC1762 |
Dgts(16:0/16:0)
Abundant lipid in the membranes of many algae, lower plants, and fungi, showing an inverse concentration relationship with phosphatidylcholine, being capable of replacing phosphatidylcholine |
1607456-57-4 |
DCC1763 |
Dgy-08-097
Novel HCV NS3 degrader, reducing susceptibility to resistance mutations, potently inhibiting HCV in a cellular infection model, exhibiting the most potent degradation (DC50 of 50nM at 4h) of HCV NS3, |